Erik Henke

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

Oncogene

Biology direct

Nature communications

Histochemistry and cell biology

Universität Würzburg

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universität Würzburg Sep 09 2013

Germany

Principal Investigator :: Institut für Anatomy and Cell Biology II

Universitätsklinikum Würzburg Jul 01 2010 - Jun 30 2013

Germany

DFG Heisenberg Fellow :: Institut of Clinical Biochemistry and Pathobiochemistry

Memorial Sloan Kettering Cancer Center Dec 01 2002 - Apr 30 2010

United States

Research Associate :: Cancer Biology and Genetics

Publications

Helene Hoffmann, Martin Wartenberg, Sandra Vorlova, Franziska Karl-Schöller, Matthias Kallius, Oliver Reinhardt, Asli Öztürk, Leah S Schuhmair, Verena Burkhardt, Sabine Gätzner, Daniela Scheld, Rajender Nandigama, Alma Zernecke, Sabine Herterich, Süleyman Ergün, Andreas Rosenwald, Erik Henke
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer. Oncogene 43 (35) (2024)
Helene Hoffmann, Martin Wartenberg, Sandra Vorlova, Franziska Karl-Schöller, Matthias Kallius, Oliver Reinhardt, Asli Öztürk, Leah S Schuhmair, Verena Burkhardt, Sabine Gätzner, Daniela Scheld, Rajender Nandigama, Alma Zernecke, Sabine Herterich, Süleyman Ergün, Andreas Rosenwald, Erik Henke
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer. Oncogene (2024)
David Ascheid, Magdalena Baumann, Jürgen Pinnecker, Mike Friedrich, Daniel Szi-Marton, Cornelia Medved, Maja Bundalo, Vanessa Ortmann, Asli Öztürk, Rajender Nandigama, Katherina Hemmen, Süleymann Ergün, Alma Zernecke, Matthias Hirth, Katrin G Heinze, Erik Henke
A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy. Nature communications 15 (1) (2024)
Helene Hoffmann, Martin Wartenberg, Sandra Vorlova, Franziska Karl-Schöller, Matthias Kallius, Oliver Reinhardt, Asli Öztürk, Leah S Schuhmair, Verena Burkhardt, Sabine Gätzner, Daniela Scheld, Rajender Nandigama, Alma Zernecke, Sabine Herterich, Süleyman Ergün, Andreas Rosenwald, Erik Henke
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer. Oncogene 43 (35) (2024)
Helene Hoffmann, Martin Wartenberg, Sandra Vorlova, Franziska Karl-Schöller, Matthias Kallius, Oliver Reinhardt, Asli Öztürk, Leah S Schuhmair, Verena Burkhardt, Sabine Gätzner, Daniela Scheld, Rajender Nandigama, Alma Zernecke, Sabine Herterich, Süleyman Ergün, Andreas Rosenwald, Erik Henke
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer. Oncogene 43 (35) (2024)
David Ascheid, Magdalena Baumann, Jürgen Pinnecker, Mike Friedrich, Daniel Szi-Marton, Cornelia Medved, Maja Bundalo, Vanessa Ortmann, Asli Öztürk, Rajender Nandigama, Katherina Hemmen, Süleymann Ergün, Alma Zernecke, Matthias Hirth, Katrin G Heinze, Erik Henke
A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy. Nature communications 15 (1) (2024)
David Ascheid, Magdalena Baumann, Caroline Funke, Julia Volz, Jürgen Pinnecker, Mike Friedrich, Marie Höhn, Rajender Nandigama, Süleyman Ergün, Bernhard Nieswandt, Katrin G Heinze, Erik Henke
Image-based modeling of vascular organization to evaluate anti-angiogenic therapy. Biology direct 18 (1) (2023)
David Ascheid, Magdalena Baumann, Caroline Funke, Julia Volz, Jürgen Pinnecker, Mike Friedrich, Marie Höhn, Rajender Nandigama, Süleyman Ergün, Bernhard Nieswandt, Katrin G Heinze, Erik Henke
Image-based modeling of vascular organization to evaluate anti-angiogenic therapy. Biology direct 18 (1) (2023)
David Ascheid, Magdalena Baumann, Caroline Funke, Julia Volz, Jürgen Pinnecker, Mike Friedrich, Marie Höhn, Rajender Nandigama, Süleyman Ergün, Bernhard Nieswandt, Katrin G Heinze, Erik Henke
Image-based modeling of vascular organization to evaluate anti-angiogenic therapy. Biology direct 18 (1) (2023)
David Ascheid, Magdalena Baumann, Caroline Funke, Julia Volz, Jürgen Pinnecker, Mike Friedrich, Marie Höhn, Rajender Nandigama, Süleyman Ergün, Bernhard Nieswandt, Katrin G Heinze, Erik Henke
Image-based modeling of vascular organization to evaluate anti-angiogenic therapy. Biology direct 18 (1) (2023)
Berin Upcin, Erik Henke, Florian Kleefeldt, Helene Hoffmann, Andreas Rosenwald, Ster Irmak-Sav, Huseyin Bertal Aktas, Uwe Rückschloß, Süleyman Ergün
Contribution of Adventitia-Derived Stem and Progenitor Cells to New Vessel Formation in Tumors. Cells 10 (7) (2021)
Bertal H Aktas, Berin Upcin, Erik Henke, Manju Padmasekar, Xuebin Qin, Süleyman Ergün
The Best for the Most Important: Maintaining a Pristine Proteome in Stem and Progenitor Cells. Stem cells international 2019 (2019)
Julia Volz, Elmina Mammadova-Bach, Jesus Gil-Pulido, Rajender Nandigama, Katharina Remer, Lydia M Sorokin, Alma Zernecke, Scott I Abrams, Süleyman Ergün, Erik Henke, Bernhard Nieswandt
Inhibition of platelet GPVI induces intratumor hemorrhage and increases efficacy of chemotherapy in mice. Blood 133 (25) (2019)
Philipp Wörsdörfer, Nahide Dalda, Anna Kern, Sarah Krüger, Nicole Wagner, Chee Keong Kwok, Erik Henke, Süleyman Ergün
Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells. Scientific reports 9 (1) (2019)
Rajender Nandigama, Berin Upcin, Bertal H Aktas, Süleyman Ergün, Erik Henke
Restriction of drug transport by the tumor environment. Histochemistry and cell biology 150 (6) (2018)

Erik Henke.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Erik Henke